| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/15/2003 | CA2466145A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 05/15/2003 | CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 05/15/2003 | CA2464757A1 Selective antibacterial agents |
| 05/14/2003 | EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof |
| 05/14/2003 | EP0971915B1 Method for preparing 2-thienylethylamine derivatives |
| 05/14/2003 | EP0970077B1 Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 05/14/2003 | EP0769945B1 Use of 2-phenyl-3-aroylbenzothiophene derivatives for the manufacture of a medicament for bone healing and fracture repair |
| 05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 05/14/2003 | CN1108295C Thiol derivatives with metallopeptidase (ACE/NEP) inhibitory activity |
| 05/14/2003 | CN1108288C Benzyloxy substituted aromatics and their use as fungicides |
| 05/13/2003 | US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst |
| 05/13/2003 | US6562862 Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| 05/13/2003 | US6562842 Osteoporosis, oral diseases |
| 05/13/2003 | US6562840 Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitors |
| 05/13/2003 | US6562817 Suppressants of the IgE production |
| 05/13/2003 | US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 05/08/2003 | WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/08/2003 | WO2003037886A2 Heteroaromatic carboxamide derivatives for the treatment of inflammation |
| 05/08/2003 | WO2003037865A1 Novel anticancer compounds |
| 05/08/2003 | WO2003037853A1 Substituted thioacetamides |
| 05/08/2003 | WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 05/08/2003 | WO2003037326A1 Solid phase synthesis of chemical libraries |
| 05/08/2003 | US20030087945 Sulfonylaminocarboxylic acids |
| 05/08/2003 | US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/08/2003 | US20030087126 Hydrocarbon compound, material for organic electroluminescent element and organic electroluminescent element |
| 05/08/2003 | US20030086666 Novel nonlinear optical polymers incorporating amines |
| 05/08/2003 | US20030085388 Novel nonlinear optical compounds and polymers |
| 05/08/2003 | US20030085381 For use in optical, electrooptical or electronic device, like for example components of integrated circuitry, field effect transistors (FET) for example as thin film transistors in flat panel display or for Radio Frequency Identification tags |
| 05/08/2003 | CA2468761A1 Novel anticancer compounds |
| 05/08/2003 | CA2464924A1 Heteroaromatic carboxamide derivatives for the treatment of inflammation |
| 05/08/2003 | CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/08/2003 | CA2462206A1 Substituted thioacetamides |
| 05/08/2003 | CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 05/07/2003 | EP1308781A2 Cyclic sulfonium and sulfoxonium photoacid generators and photoresists containing them |
| 05/07/2003 | EP1308436A1 Calcium receptor antagonists |
| 05/07/2003 | EP1308435A2 Process for producing optically active amino alcohols |
| 05/07/2003 | EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers |
| 05/07/2003 | EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/07/2003 | EP1019358B1 3,3-diarylpropylamines , their use and preparation |
| 05/07/2003 | EP0938491B1 Heterocyclic metallocenes and polymerization catalysts |
| 05/07/2003 | EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides |
| 05/07/2003 | EP0889863B1 Surface modified carbonate materials |
| 05/07/2003 | EP0888330B1 Methods of treating or preventing interstitial cystitis |
| 05/07/2003 | EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha) |
| 05/07/2003 | EP0751765B1 Sulfonamide derivatives and their use |
| 05/07/2003 | EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity |
| 05/07/2003 | CN1415619A Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 05/07/2003 | CN1107502C Prepn. method for medicinal compsn. contg. hydrogonated pyridine derivative as active components |
| 05/06/2003 | US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 05/06/2003 | US6559323 Degradation of hydrazone compound to diazo compound; catalysis with transition metal; reaction with sulfide |
| 05/06/2003 | US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use |
| 05/06/2003 | US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound. |
| 05/06/2003 | US6559145 Heterocycle carboxamides as antiviral agents |
| 05/06/2003 | US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 05/06/2003 | US6559100 2-benzoyl-cyclohexane-1,3-diones |
| 05/06/2003 | CA2244194C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/02/2003 | EP1305306A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 05/02/2003 | EP1305305A1 Hyperpolarizable organic chromophores |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305292A1 Biphenyl carboxamides |
| 05/02/2003 | EP1305270A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 05/02/2003 | EP1305028A2 Antimicrobial biaryl compounds |
| 05/02/2003 | EP1305023A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 05/02/2003 | EP1105381B1 Dibenzothiophene compounds and methods of use thereof |
| 05/02/2003 | EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 05/02/2003 | EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 05/01/2003 | WO2003035714A1 Triarylamine containing monomers for optoelectronic devices |
| 05/01/2003 | WO2003035629A1 Thiopene- amd thiazolesulfonamides as antineoplastic agents |
| 05/01/2003 | WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 05/01/2003 | WO2003035620A1 Bicyclic compound |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2003035057A1 Inhibitors of dipeptidyl peptidase iv |
| 05/01/2003 | WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
| 05/01/2003 | WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 05/01/2003 | WO2002044113A9 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 05/01/2003 | US20030083523 Amide derivatives |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030083362 Synthesis and antimicrobial activity of novel dicationic"reversed amidines" |
| 05/01/2003 | US20030083359 Treating pain, urinary incontinence and bladder overactivity; P2X receptors are cation-permeable ion channels |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 04/30/2003 | CN1414963A Novel heteroary derivatives, their preparation and use |
| 04/30/2003 | CN1414942A Preparing method of 2-phenylalkanoic acid derivatives |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107049C Benzyloxy substituted aromatics and their use as fungicides and insecticides |
| 04/30/2003 | CA2409906A1 Process for producing optically active amino alcohols and intermediates therefor |
| 04/29/2003 | US6555697 Method of preparing a benzofuran or benzothiophene compound |
| 04/29/2003 | US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
| 04/29/2003 | US6555570 Growth hormone secretagogous with improved bioavailability |
| 04/29/2003 | US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 04/29/2003 | US6555555 Fused thiophone derivatives and drugs containing the same as the active ingredient |
| 04/24/2003 | WO2003033503A2 Method for producing, via organometallic compounds, organic intermediate products |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |